Articles

Clinicians, researchers and stakeholders discussed establishing CVI diagnostic criteria, boosting awareness of CVI and creating a participant data registry

Euan Thomson, Head of the Ophthalmology Strategic Business Unit and Head of the Digital Business Unit at Carl Zeiss Meditec, discusses plans for the company's vitreoretinal surgery workflows following announcement of DORC acquisition

A strategic distribution partnership is expected to make Morrow’s eProgressive smart glasses available to consumers in the second quarter of 2024

The UK-based Rayner announced the acquisition will enhance its portfolio in the cataract surgery space

Dr Edmond has also served as president of the American Association for Paediatric Ophthalmology and Strabismus and an oral examiner for the American Board of Ophthalmology

The trial will use vision preservation as a primary outcome measure, according to Annexon

eSight, a wearable assistive technology company, produces comprehensive equipment for patients with over 20 ocular disorders

A reduction in clinical exposure has harmed student confidence, according to a questionnaire administered in the United Kingdom

The European Union approval applies to aflibercept 8 mg for treatment of nAMD and DME

Prevent Blindness will offer downloadable fact sheets, shareable social media graphics and educational videos for patients

Catch up on Modern Retina's top stories, and ones you may have missed in 2023

A look back at some of the biggest stories in 2023, from our US partners at Ophthalmology Times

From FDA approvals to innovations in lens tech, 2023 was a big year in eye care

A review of our most important content from throughout the year

Real-world data from using faricimab to treat neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME)

The technology provides effective, efficient evaluations when paired with the right patients

In 2024, the waiting game will pay off for glaucoma specialists who are eager to develop fluency and implement new devices into their practices

Analysis suggested no evidence for a causal association of lifetime cannabis use and cannabis use disorder with primary open-angle glaucoma

The case for treating keratoconus without waiting for disease progression

Why “acceleration” is the industry keyword for 2024

EXN407 has the potential to be the first topical treatment for diabetic retinopathy and diabetic macular oedema

The study results will help to identify dosing levels for future clinical trials

Working smarter, not harder, to benefit patients

Experts from around the globe converged in San Francisco, California

Austrian investigators recommend an interdisciplinary, rheumatologic–ophthalmologic approach to disease management

Restoration and regeneration represent a new paradigm

A retrospective observational study shows BCVA was maintained after 6 months for patients with neovascular AMD

In recognition of global Geographic Atrophy Week, Prevent Blindness is providing free educational resources on GA for patients, care partners and healthcare professionals

At this year’s EURETINA meeting, retina specialists highlighted important developments in diabetic macular oedema and diabetic retinopathy research

Data show transfection in both eyes despite unilateral injection